CSI Market
Sign In | Register

Corcept Therapeutics Inc (CORT) Annual Balance Sheets

Annual · GAAP · USD millions
Access CORT quarterly Balance Sheets →
The data below summarizes Corcept Therapeutics Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent120.50
Marketable Securities, Current SH251.66
Cash & Short-term Investments371.00
Accounts receivable59.79
Inventories12.87
Other Current Assets0.00
Prepaid Expense And Other Assets Current40.66
Total Current Assets485.46
Equipment/Property/Plant Net1.89
Long-term investments160.27
Other Assets, Noncurrent349.30
Loss Contingency Receivable Current-
Operating Lease Right Of Use Asset4.58
Deferred Income Tax Assets Net168.20
Total Assets836.65
Liabilities
Accounts Payable, Current AC40.44
Accrued Liabilities, Current AC90.60
Other Liabilities, Current35.04
Total Current Liabilities166.09
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent AC115.18
Other liabilities, Noncurrent7.59
Accrued Clinical Expenses Current33.95
Operating Lease Liability Current1.08
Operating Lease Liability Noncurrent5.02
Total Liabilities188.85
Stockholders' Equity
Treasury Stock Common Value-966.59
Common Stock Value0.14
Additional Paid In Capital Common Stock968.60
Retained Earnings / Accumulated Deficit643.39
Other Equity2.26
Common Stockholder's Equity647.81
Total Stockholder's Equity647.81
Liabilities & Stockholder's Equity836.65
4 historic quarters locked

Sign in to unlock the full Corcept Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Corcept Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: cort-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-011091

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.